Category: Cerner Corp.Syndicate content

On-Q-ity folds its tents after 3 years, $26M | Wall Street Beat

April 12, 2013 by Brad Perriello

Oncology diagnostics company On-Q-ity folds up its tents after an unsuccessful, 3-year bid to develop personalized cancer diagnostics – and burning through $26 million in venture capital backing.

MassDevice.com Wall Street Beat

On-Q-ity, which raised a $26 million Series A round back in December 2009, quietly folded its tents last year after an unsuccessful bid to develop its technology for personalized cancer detection.

Bruce Booth, a partner at Atlas Ventures, 1 of the VC shops that backed the company (and a member of On-Q-ity's board), detailed the reasons behind the decision this week on his blog, Life Sci VC.

Medical device makers ink interoperability pledge

January 15, 2013 by MassDevice staff

Nine prominent medical device companies sign on to a pledge to increase the interoperability of their products in the interest of patient safety.

Patient Safety Science & Technology Summit

Nine medical device companies ranging from industry titans to small-cap movers inked a pledge to make the data generated by their devices available to patients, in a move aimed at ridding the healthcare system of unnecessary deaths by 2020.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Blackstone leads race for Allscripts | Wall Street Beat

December 3, 2012 by MassDevice staff

Private equity firm Blackstone Group leads the pack pursuing a buyout of Allscripts, according to Reuters.

MassDevice.com Wall Street Beat

Blackstone Group is said to be leading the bidding war for electronic medical records company Allscripts (NSDQ:MDRX) but the 2 sides are far from agreeing on a price, according to Reuters.

Citing 3 "people familiar with the matter," the news agency said a deal is "highly uncertain."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA clears Cerner's iPhone-friendly mobile fetal monitoring system

November 14, 2012 by MassDevice staff

Cerner lands FDA clearance for its Cerner FetaLink+, a mobile maternal and fetal monitoring device that could help clinicians provide high level of care for patients.

Cerner logo

Kansas City, Mo.-based healthcare provider Cerner (NSDQ:CERN) received FDA clearance to market its mobile maternal and fetal monitoring system, called Cerner FetaLink+, a device that help clinicians monitor mothers and babies using iPads or iPhones.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat

March 28, 2012 by MassDevice staff

Hill-Rom Holdings says it plans to lay off 200 workers, or 3% of its workforce, in part due to the looming medical device tax; also, AngioDynamics drops $5M on Microsulis; Kips Bay switches NASDAQ markets; Luna Innovations, Intuitive Surgical extend pact; Asahi Kasei begins $2B bid for Zoll; CRO Cetero files for bankruptcy after FDA probe; NASDAQ warns NeuroMetrix; the 6 players that dominate the EMR market; Intuitive Surgical, GE, Hitachi, Philips win federal contracts; plus a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

GE, Masimo ink OEM deal | Wall Street Beat

March 1, 2012 by MassDevice staff

GE Healthcare will integrate Masimo's Rainbow SET technology into its patient monitoring devices; also, NASDAQ adds Novadaq; ConMed launches dividend program; Align Technology's R&D head cashes in; GPOs: Premier inks deals with Bard, GE, Philips; a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

GE Healthcare (NYSE:GE) and Masimo (NSDQ:MASI) inked a long-term deal that will see GE integrate Masimo's Rainbow SET technology into many of its patient monitoring products.

Is Boston Scientific in line for a private equity takeover? | Wall Street Beat

February 24, 2012 by MassDevice staff

Is hedge fund giant David Tepper's new stake in Boston Scientific an indication that it's ripe for a private equity buyout?; also, OTC lists Titan Medical; Burrill & Co. opens in Taiwan; MGT Capital plans reverse split to stay on NYSE; plus a Deals Roundup, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp